Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

NCT06373523 is registered in ClinicalTrials.gov with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor.

NCT NCT06373523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06373523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 15, 2024
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steato-fibrosis, non-alcoholic fatty liver disease